Skip to content
Evigrade
MajorNon-steroidal anti-inflammatory drug, propionic acid derivative×Calcineurin inhibitor (immunosuppressant)

Updated · Methodology

Mechanism

Tacrolimus can impair renal function on its own. Drugs with known nephrotoxic or neurotoxic effects, including non-steroidal anti-inflammatory drugs (NSAIDs), may potentiate these effects of tacrolimus (tacrolimus summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Ketoprofen is an NSAID. Its SmPC states that NSAIDs may increase the nephrotoxicity of tacrolimus through effects mediated by renal prostaglandins (ketoprofen SmPC, AEMPS). Ketoprofen can cause hyperkalaemia, especially in diabetes, renal impairment or with other drugs that raise potassium. The ketoprofen SmPC names tacrolimus among these drugs (AEMPS). Tacrolimus is more than 98.8% bound to plasma proteins and ketoprofen about 99%. The tacrolimus SmPC asks prescribers to consider possible interactions with other highly protein-bound drugs, including NSAIDs (AEMPS).

Symptoms

Tacrolimus very commonly impairs renal function and causes hyperkalaemia. Common reactions include oliguria and renal failure, including acute renal failure (tacrolimus summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Acute renal impairment from tacrolimus toxicity can show as high serum creatinine, hyperkalaemia, reduced urea excretion and hyperuricaemia, and is usually reversible (tacrolimus label, US Food and Drug Administration, FDA). Like all non-steroidal anti-inflammatory drugs, ketoprofen can raise blood urea nitrogen and creatinine. Its adverse reactions include hyperkalaemia, acute renal failure, tubulointerstitial nephritis, nephritic syndrome and oedema (ketoprofen SmPC, AEMPS).

Management

The combination is not contraindicated. The tacrolimus summary of product characteristics (SmPC) recommends avoiding tacrolimus with drugs that have known nephrotoxic effects and explicitly lists non-steroidal anti-inflammatory drugs (NSAIDs) among them. Ketoprofen belongs to this class (tacrolimus SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). If the combination cannot be avoided, closely monitor tacrolimus trough blood levels, renal function and other adverse effects. Adjust the tacrolimus dose if needed, and consider reducing it if nephrotoxicity occurs (AEMPS). Monitor renal function and blood potassium throughout combined use of ketoprofen and tacrolimus (ketoprofen SmPC, AEMPS). The US tacrolimus label says to monitor renal function and tacrolimus blood levels when tacrolimus is combined with other known nephrotoxic drugs. During concurrent use, adjust the dose of tacrolimus, the other drug or both, and check serum potassium periodically (tacrolimus label, US Food and Drug Administration, FDA). Ketoprofen is contraindicated in moderate to severe renal impairment. Use it with caution in renal impairment, in older people and when hypovolaemia may develop (ketoprofen SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Ketoprofen

Other interactions with Tacrolimus